Anne Fournier

Anne Fournier

Auto-generated profile, based on publicly available information

Anne Fournier

Division of Pediatric Cardiology, CHU Sainte-Justine, Université de Montréal, Quebec, Canada (A.F.).

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2020 in Current Cardiology Reports
Verified
Journal Article
Open access
PDF file
NGNicholas Grubic
Nicholas Grubic
JPJake Puskas
Jake Puskas
DPDermot Phelan
Dermot Phelan
AFAnne Fournier
Anne Fournier
LMLuc J. Martin
Luc J. Martin
AJAmer M Johri
Amer M Johri
Purpose of Review Although rare, sudden cardiac death (SCD) in the young is a tragic event, having a dramatic impact upon all involved. The psychosocial burden associated with SCD can leave friends, families, and entire communities bereft. With only limited evidence to describe the volatile emotional reactions associated with a young SCD, there is an urgent need for care providers to better understand the psychological complexities and impacts faced by both at-risk individuals and those directly affected by these tragic events. Recent Findings Current knowledge of the psychosocial implications associated with SCD in the young has recently generated interest in the cardiovascular community, with the goal of addressing prevention strategies (screening), family bereavement, and the psychological impact of at-risk or surviving individuals. With the emergence of novel strategies aimed at reducing the public health impact of SCD in the young, further discussion regarding the psychosocial impact of SCD, encompassing prevention, survivorship, and the downstream communal effects of a young death is required. Support systems and intervention could assist in the management of the associated psychosocial burden, yet there is a lack of clinical guidelines to direct this form of care. Summary There is an important need for multidisciplinary collaboration across subspecialties to provide support to grieving individuals and manage patient well-being throughout the screening process for SCD. This collaborative approach requires the integration of cardiovascular and psychological expertise where relevant.

1 June 2021 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Closed access
PDF file
BDBrianna Davies
Brianna Davies
KBKirsten Bartels
Kirsten Bartels
JHJulie Hathaway
Julie Hathaway
FXFang Xu
Fang Xu
JRJason D. Roberts
Jason D. Roberts
ZLZachary Laksman
Zachary Laksman
Background: Following an unexplained cardiac arrest, clinical genetic testing is increasingly becoming standard of care. Periodic review of variant classification is required, as reinterpretation can change the diagnosis, prognosis, and management of patients and their relatives. Methods: This study aimed to develop and validate a standardized algorithm to facilitate clinical application of the 2015 American College of Medical Genetics and Association for Molecular Pathology guidelines for the interpretation of genetic variants. The algorithm was applied to genetic results in the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry, to assess the rate of variant reclassification over time. Variant classifications were then compared with the classifications of 2 commercial laboratories to determine the rate and identify sources of variant interpretation discordance. Results: Thirty-one percent of participants (40 of 131) had at least 1 genetic variant with a clinically significant reclassification over time. Variants of uncertain significance were more likely to be downgraded (73%) to benign than upgraded to pathogenic (27%; P =0.03). For the second part of the study, 50% (70 of 139) of variants had discrepant interpretations (excluding benign variants), provided by at least 1 team. Conclusions: Periodic review of genetic variant classification is a key component of follow-up care given rapidly changing information in the field. There is potential for clinical care gaps with discrepant variant interpretations, based on the interpretation and application of current guidelines. The development of gene- and disease-specific guidelines and algorithms may provide an opportunity to further standardize variant interpretation reporting in the future. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00292032.

27 November 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
NDNabil DIB
Nabil DIB
NPNancy Poirier
Nancy Poirier
MSMichelle Samuel
Michelle Samuel
SHSewanou Hermann Honfo
Sewanou Hermann Honfo
AZAli Zaidi
Ali Zaidi
PKPaul Khairy
Paul Khairy
Background: The univentricular heart with a predominant right ventricle morphology (uRV) has been associated with a higher rate of adverse cardiovascular events. It remains to be determined whether the specific type of uRV influences outcomes. Methods and Results: A North American multicenter retrospective cohort study was conducted by the Alliance for Adult Research in Congenital Cardiology on individuals with a uRV and total cavopulmonary connection Fontan. The incidence of a composite outcome consisting of all‐cause mortality, cardiac transplantation, atrial arrhythmias, or thromboembolic events was compared among patients with Fontan palliation who had hypoplastic left heart syndrome (HLHS) versus other forms of uRV (non‐HLHS). All components of the composite outcome were classified by a blinded adjudicating committee. Competing risks were taken into account in time‐to‐event analyses. A total of 171 patients with uRV of whom 76 (44.4%) had HLHS were followed for 10.2±5.7 years. The composite outcome occurred in 7.1 versus 2.1 cases per 100 person‐years in patients with HLHS versus non‐HLHS ( P <0.0001). In multivariable analyses, HLHS was associated with a significantly higher risk of the composite outcome (hazard ratio [HR], 6.13 [95% CI, 2.92–12.69], P <0.001). Moreover, HLHS was associated with significantly higher rates of all components of the primary outcome. Conclusions: Among patients with a uRV and Fontan palliation, HLHS is associated with a significantly higher rate of adverse cardiovascular events.

14 September 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
LYLauren A. Yee
Lauren A. Yee
HHHui‐Chen Han
Hui‐Chen Han
BDBrianna Davies
Brianna Davies
CPCharles M. Pearman
Charles M. Pearman
ZLZachary Laksman
Zachary Laksman
AKAndrew D. Krahn
Andrew D. Krahn
Background: Diagnosis of congenital long‐QT syndrome (LQTS) is complicated by phenotypic ambiguity, with a frequent normal‐to‐borderline resting QT interval. A 3‐step algorithm based on exercise response of the corrected QT interval (QTc) was previously developed to diagnose patients with LQTS and predict subtype. This study evaluated the 3‐step algorithm in a population that is more representative of the general population with LQTS with milder phenotypes and establishes sex‐specific cutoffs beyond the resting QTc. Methods and Results: We identified 208 LQTS likely pathogenic or pathogenic KCNQ1 or KCNH2 variant carriers in the Canadian NLQTS (National Long‐QT Syndrome) Registry and 215 unaffected controls from the HiRO (Hearts in Rhythm Organization) Registry. Exercise treadmill tests were analyzed across the 5 stages of the Bruce protocol. The predictive value of exercise ECG characteristics was analyzed using receiver operating characteristic curve analysis to identify optimal cutoff values. A total of 78% of male carriers and 74% of female carriers had a resting QTc value in the normal‐to‐borderline range. The 4‐minute recovery QTc demonstrated the best predictive value for carrier status in both sexes, with better LQTS ascertainment in female patients (area under the curve, 0.90 versus 0.82), with greater sensitivity and specificity. The optimal cutoff value for the 4‐minute recovery period was 440 milliseconds for male patients and 450 milliseconds for female patients. The 1‐minute recovery QTc had the best predictive value in female patients for differentiating LQTS1 versus LQTS2 (area under the curve, 0.82), and the peak exercise QTc had a marginally better predictive value in male patients for subtype with (area under the curve, 0.71). The optimal cutoff value for the 1‐minute recovery period was 435 milliseconds for male patients and 455 milliseconds for femal patients. Conclusions: The 3‐step QT exercise algorithm is a valid tool for the diagnosis of LQTS in a general population with more frequent ambiguity in phenotype. The algorithm is a simple and reliable method for the identification and prediction of the 2 major genotypes of LQTS.

1 November 2014 in The American Journal of Cardiology
Verified
Journal Article
Closed access
GAGabriel Altit
Gabriel Altit
GSGeorgia Sarquella-Brugada
Georgia Sarquella-Brugada
NDNagib Dahdah
Nagib Dahdah
FDFrédéric Dallaire
Frédéric Dallaire
ACAna Maria Carceller
Ana Maria Carceller
AFAnne Fournier
Anne Fournier

16 April 2013 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
IBIbtissama Boukas
Ibtissama Boukas
NDNagib Dahdah
Nagib Dahdah
YRYves Robitaille
Yves Robitaille
AFAnne Fournier
Anne Fournier